| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16130065 |
| PharmacoGx | BRD-K16130065 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MT-ND3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | ZNF569 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | KAT14 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | CDADC1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | ARHGEF39 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | COG5 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | LRRC37A | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | TSPY4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | FGF2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | TANC2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
